ArticleCell death & disease2025

Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.

Lihua Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.